Merck Files for FDA Approval for Rotavirus Vaccine

April 12, 2005

Merck has filed for approval for Rotateq, its vaccine to protect against rotavirus gastroenteritis. Merck also announced that it has plans to file for licensure of Rotateq in Australia, Canada, the EU and Mexico, as well as countries in Asia and Latin America in 2005.More information:

Pharmaceutical Business Review online
Medical News Today
Merck Press Release

Topics

Vaccines

DISCLAIMER & PERMISSIONS

CGD's publications reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions. You may use and disseminate CGD's publications under these conditions.